HCPLive
@hcplivenews.bsky.social
Everything you need to enhance your approach to improving patient care.
Kassandra Holzem, MD, of @MedicalCollege, sat down in an interview with HCPLive at the #SDPAFall2025.🎥
In her on-camera discussion, Holzem was asked about her session ‘Difficult Cases & Red Flags in Dermatology: When to Admit From the Clinic.’
🔗View: www.hcplive.com/view/difficu...
In her on-camera discussion, Holzem was asked about her session ‘Difficult Cases & Red Flags in Dermatology: When to Admit From the Clinic.’
🔗View: www.hcplive.com/view/difficu...
November 25, 2025 at 10:05 PM
Kassandra Holzem, MD, of @MedicalCollege, sat down in an interview with HCPLive at the #SDPAFall2025.🎥
In her on-camera discussion, Holzem was asked about her session ‘Difficult Cases & Red Flags in Dermatology: When to Admit From the Clinic.’
🔗View: www.hcplive.com/view/difficu...
In her on-camera discussion, Holzem was asked about her session ‘Difficult Cases & Red Flags in Dermatology: When to Admit From the Clinic.’
🔗View: www.hcplive.com/view/difficu...
In the latest episode of Diabetes Dialogue, cohosts Natalie Bellini, DNP, and Diana Isaacs, PharmD, discuss the significant price drop for Wegovy and Ozempic. These life-changing drugs are now more accessible than ever.
Watch now: www.hcplive.com/view/diabete...
Watch now: www.hcplive.com/view/diabete...
November 21, 2025 at 9:44 PM
In the latest episode of Diabetes Dialogue, cohosts Natalie Bellini, DNP, and Diana Isaacs, PharmD, discuss the significant price drop for Wegovy and Ozempic. These life-changing drugs are now more accessible than ever.
Watch now: www.hcplive.com/view/diabete...
Watch now: www.hcplive.com/view/diabete...
New data from the phase 3b ADmirable trial show lebrikizumab effectively treats severe atopic dermatitis in patients with skin of color. Vinay Mehta, MD, breaks down what clinicians need to know at #ACAAI2025: www.hcplive.com/view/lebriki...
November 18, 2025 at 10:13 PM
New data from the phase 3b ADmirable trial show lebrikizumab effectively treats severe atopic dermatitis in patients with skin of color. Vinay Mehta, MD, breaks down what clinicians need to know at #ACAAI2025: www.hcplive.com/view/lebriki...